293 related articles for article (PubMed ID: 22474351)
21. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
Chikamori K; Hill JE; Grabowski DR; Zarkhin E; Grozav AG; Vaziri SA; Wang J; Gudkov AV; Rybicki LR; Bukowski RM; Yen A; Tanimoto M; Ganapathi MK; Ganapathi R
Leukemia; 2006 Oct; 20(10):1809-18. PubMed ID: 16932348
[TBL] [Abstract][Full Text] [Related]
22. Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment.
Sano K; Miyaji-Yamaguchi M; Tsutsui KM; Tsutsui K
PLoS One; 2008; 3(12):e4103. PubMed ID: 19116664
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid Receptor Transcriptional Activation via the BRG1-Dependent Recruitment of TOP2β and Ku70/86.
Trotter KW; King HA; Archer TK
Mol Cell Biol; 2015 Aug; 35(16):2799-817. PubMed ID: 26055322
[TBL] [Abstract][Full Text] [Related]
24. Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group.
Miyahara H; Natsumeda M; Kanemura Y; Yamasaki K; Riku Y; Akagi A; Oohashi W; Shofuda T; Yoshioka E; Sato Y; Taga T; Naruke Y; Ando R; Hasegawa D; Yoshida M; Sakaida T; Okada N; Watanabe H; Ozeki M; Arakawa Y; Yoshimura J; Fujii Y; Suenobu S; Ihara K; Hara J; Kakita A; Yoshida M; Iwasaki Y
Brain Tumor Pathol; 2021 Apr; 38(2):109-121. PubMed ID: 33704596
[TBL] [Abstract][Full Text] [Related]
25. UPR-induced resistance to etoposide is downstream of PERK and independent of changes in topoisomerase IIα levels.
Mann MJ; Pereira ER; Liao N; Hendershot LM
PLoS One; 2012; 7(10):e47931. PubMed ID: 23144714
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase IIβ regulates base excision repair capacity of neurons.
Gupta KP; Swain U; Rao KS; Kondapi AK
Mech Ageing Dev; 2012 Apr; 133(4):203-13. PubMed ID: 22433436
[TBL] [Abstract][Full Text] [Related]
27. CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression.
Yao H; Hannum DF; Zhai Y; Hill SF; Albanus RD'; Lou W; Skidmore JM; Sanchez G; Saiakhova A; Bielas SL; Scacheri P; Ljungman M; Parker SCJ; Martin DM
Sci Rep; 2020 Oct; 10(1):17445. PubMed ID: 33060836
[TBL] [Abstract][Full Text] [Related]
28. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway.
Xiao H; Mao Y; Desai SD; Zhou N; Ting CY; Hwang J; Liu LF
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3239-44. PubMed ID: 12629207
[TBL] [Abstract][Full Text] [Related]
29. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
Auzanneau C; Montaudon D; Jacquet R; Puyo S; Pouységu L; Deffieux D; Elkaoukabi-Chaibi A; De Giorgi F; Ichas F; Quideau S; Pourquier P
Mol Pharmacol; 2012 Jul; 82(1):134-41. PubMed ID: 22528119
[TBL] [Abstract][Full Text] [Related]
30. Increased negative supercoiling of mtDNA in TOP1mt knockout mice and presence of topoisomerases IIα and IIβ in vertebrate mitochondria.
Zhang H; Zhang YW; Yasukawa T; Dalla Rosa I; Khiati S; Pommier Y
Nucleic Acids Res; 2014 Jun; 42(11):7259-67. PubMed ID: 24803675
[TBL] [Abstract][Full Text] [Related]
31. Topoisomerase IIβ and its role in different biological contexts.
Bollimpelli VS; Dholaniya PS; Kondapi AK
Arch Biochem Biophys; 2017 Nov; 633():78-84. PubMed ID: 28669856
[TBL] [Abstract][Full Text] [Related]
32. Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.
Ban Y; Ho CW; Lin RK; Lyu YL; Liu LF
Mol Cell Biol; 2013 Oct; 33(20):4008-16. PubMed ID: 23938298
[TBL] [Abstract][Full Text] [Related]
33. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.
Schnetz MP; Bartels CF; Shastri K; Balasubramanian D; Zentner GE; Balaji R; Zhang X; Song L; Wang Z; Laframboise T; Crawford GE; Scacheri PC
Genome Res; 2009 Apr; 19(4):590-601. PubMed ID: 19251738
[TBL] [Abstract][Full Text] [Related]
34. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase 2β: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity.
Vejpongsa P; Yeh ET
Clin Pharmacol Ther; 2014 Jan; 95(1):45-52. PubMed ID: 24091715
[TBL] [Abstract][Full Text] [Related]
36. The function of DNA topoisomerase IIβ in neuronal development.
Heng X; Le WD
Neurosci Bull; 2010 Oct; 26(5):411-6. PubMed ID: 20882068
[TBL] [Abstract][Full Text] [Related]
37. A chromatin remodeling complex regulates topoisomerase IIα function.
Cancer Discov; 2013 Jul; 3(7):OF33. PubMed ID: 23847378
[TBL] [Abstract][Full Text] [Related]
38. 13-Cis Retinoic Acid Induces Neuronal Differentiation in Daoy (Medulloblastoma) Cells Through Epigenetic Regulation of Topoisomerase IIβ.
Chen J; Zhang JX; Lei HX; Li XY; Yan YX; Wang YL; Lv YH; Yan YL; Lei YH
Appl Biochem Biotechnol; 2023 Dec; 195(12):7429-7445. PubMed ID: 37000354
[TBL] [Abstract][Full Text] [Related]
39. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
[TBL] [Abstract][Full Text] [Related]
40. The Prevailing Role of Topoisomerase 2 Beta and its Associated Genes in Neurons.
Neha S ; Dholaniya PS
Mol Neurobiol; 2021 Dec; 58(12):6443-6459. PubMed ID: 34546528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
